Nucleobinding 1 (NUCB1) is widely expressed in brain neurons and stabilizes amyloid protofibrils before they mature and become harmful in neurodegenerative diseases [104, 105]; however, its downregulation in our COVID-19 patients suggests decreased neurological protective mechanisms. Here, NUCB1 is linked to neurodegenerative disease.